Martell Bridget A 4

What Happened

• Bridget A. Martell, a director of Delcath Systems, Inc. (DCTH), received a grant of a derivative award covering 22,500 shares on May 13, 2026. The filing records an acquisition price of $0.00 and a total reported value of $0 (derivative grant under the company's equity plan). This is an equity award (compensation), not an open-market purchase or sale.

Key Details

• Transaction date: May 13, 2026; Form 4 filed May 14, 2026 (timely filing).
• Grant type: Derivative award / stock option under the Issuer's 2020 Omnibus Equity Incentive Plan (as amended).
• Amount: 22,500 shares; reported acquisition price: $0.00.
• Vesting/exercise: Vests at 1/12th per month beginning May 13, 2026, while the director remains in service. Option expires the earlier of 10 years from grant or (for vested options) two years after last day of service. (See filing footnote for plan terms.)
• Shares owned after transaction: Not specified in the provided summary of the filing.
• Filing timeliness: Filed the next day — not reported as late.

Context

• This was a compensation-style option grant to a director. Derivative grants do not require an immediate cash outlay; value is realized only if/when the option is exercised and the shares are sold.
• Awards to directors are common and primarily reflect compensation practices; they are informational but do not necessarily signal the director's near-term trading intent. Consult the full Form 4 and the company's equity plan for complete terms (including any exercise price, restrictions, and tax implications).